This tumor-intrinsic function of PD-L1, which is achieved via the protein tyrosine phosphatase1B (PTP1B)/p38-MAPK/glycogen synthase kinase 3β (GSK3β) axis and can be activated by PD-1 binding, regulates the aggressiveness of TNBC cells. This evidence concerns the gene CD274 and neoplasm.